What it is
SLU-PP-332 is a synthetic small molecule, not a peptide. It was designed to activate estrogen-related receptors (ERRs), which regulate energy metabolism in muscle.
What the research says
- A mouse study reported that a synthetic ERR agonist changed metabolic measures in animals [1].
- We found no human trials.
Regulatory status
SLU-PP-332 is preclinical research only. It is not FDA approved for any use, and compounded versions are not FDA approved. Where prescribed, compounded versions are prepared by state-licensed 503A compounding pharmacies.
Safety and side effects
We found no human safety data for SLU-PP-332. With no human data, side effects in people are unknown, and any use would need extensive review by a licensed provider.
Is it right for you?
Only a licensed healthcare provider can decide whether any treatment is appropriate for you.
Frequently asked questions
Has SLU-PP-332 been studied in people?
No human trials were found. The peer-reviewed work cited here is in mice [1].
Is SLU-PP-332 approved by FDA?
No. SLU-PP-332 is not FDA approved and is preclinical.
Do I need a prescription for SLU-PP-332?
Yes. Prescription only, requires evaluation by a licensed provider. A provider decides whether it is appropriate for you.
Sources
- Billon C, et al. J Pharmacol Exp Ther, 2024 (mouse study). https://pmc.ncbi.nlm.nih.gov/articles/PMC10801787/
SLU-PP-332 content on this page is for education. Compounded medications are not FDA approved. Prescription only, requires evaluation by a licensed provider. Educational content only, not medical advice.